|
CREM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.83150000000665E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66990000000289E-05 |
| Normal-vs-Stage2 |
6.07069999999377E-05 |
| Normal-vs-Stage3 |
1.986850E-04 |
| Normal-vs-Stage4 |
3.485700E-02 |
| Stage1-vs-Stage2 |
7.591000E-01 |
| Stage1-vs-Stage3 |
1.749960E-01 |
| Stage1-vs-Stage4 |
3.225400E-01 |
| Stage2-vs-Stage3 |
4.726400E-01 |
| Stage2-vs-Stage4 |
3.968600E-01 |
| Stage3-vs-Stage4 |
5.418000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.766500000002E-05 |
| Normal-vs-AfricanAmerican |
4.3667000000025E-05 |
| Normal-vs-Asian |
9.583600E-04 |
| Caucasian-vs-AfricanAmerican |
6.971400E-01 |
| Caucasian-vs-Asian |
8.198600E-01 |
| AfricanAmerican-vs-Asian |
9.190200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.24969999998992E-05 |
| Normal-vs-Female |
1.209020E-04 |
| Male-vs-Female |
4.330200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.74929999999996E-05 |
| Normal-vs-Extreme_Weight |
5.72999999999269E-05 |
| Normal-vs-Obese |
4.33779999999828E-05 |
| Normal-vs-Extreme_Obese |
3.85560000000229E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.238000E-01 |
| Normal_Weight-vs-Obese |
6.238000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.354000E-01 |
| Extreme_Weight-vs-Obese |
8.407000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.234800E-01 |
| Obese-vs-Extreme_Obese |
5.970000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.177600E-04 |
| Normal-vs-Age(41-60Yrs) |
6.09569999999726E-05 |
| Normal-vs-Age(61-80Yrs) |
2.19200000000086E-05 |
| Normal-vs-Age(81-100Yrs) |
3.94630000000173E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.280400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.204300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.518200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.145420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.095000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.287800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.43030000000033E-05 |
| Normal-VS-Type2 PRCC |
1.7315099999915E-05 |
| Normal-VS-KIRP CIMP |
4.193400E-01 |
| Normal-VS-Unclassified PRCC |
1.82903000000012E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.933000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.618100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.099200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.950200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.485800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.760800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.96169999997242E-06 |
| Normal-vs-N1 |
3.832500E-04 |
| Normal-vs-N2 |
3.953600E-01 |
| N0-vs-N1 |
3.050400E-02 |
| N0-vs-N2 |
3.555000E-01 |
| N1-vs-N2 |
5.620800E-01 |
|
|
